185 related articles for article (PubMed ID: 12911563)
1. Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients.
Heine GH; Ulrich C; Sester U; Sester M; Köhler H; Girndt M
Kidney Int; 2003 Sep; 64(3):1101-7. PubMed ID: 12911563
[TBL] [Abstract][Full Text] [Related]
2. Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake?
Heine GH; Ulrich C; Köhler H; Girndt M
Am J Nephrol; 2004; 24(4):461-8. PubMed ID: 15331890
[TBL] [Abstract][Full Text] [Related]
3. Elevated erythropoietin receptor and transforming growth factor-beta1 expression in stenotic arteriovenous fistulae used for hemodialysis.
Ikegaya N; Yamamoto T; Takeshita A; Watanabe T; Yonemura K; Miyaji T; Ohishi K; Furuhashi M; Maruyama Y; Hishida A
J Am Soc Nephrol; 2000 May; 11(5):928-935. PubMed ID: 10770972
[TBL] [Abstract][Full Text] [Related]
4. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.
Rao M; Guo D; Jaber BL; Tighiouart H; Pereira BJ; Balakrishnan VS;
Kidney Int; 2004 Jul; 66(1):419-27. PubMed ID: 15200451
[TBL] [Abstract][Full Text] [Related]
6. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
[TBL] [Abstract][Full Text] [Related]
7. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis.
Chen HY; Chiu YL; Chuang YF; Hsu SP; Pai MF; Lai CF; Yang JY; Peng YS; Tsai TJ; Wu KD
Am J Kidney Dis; 2010 Oct; 56(4):720-7. PubMed ID: 20801568
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access.
Weiss MF; Scivittaro V; Anderson JM
Am J Kidney Dis; 2001 May; 37(5):970-80. PubMed ID: 11325679
[TBL] [Abstract][Full Text] [Related]
9. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
[TBL] [Abstract][Full Text] [Related]
10. The association of genotype polymorphisms with vascular access patency in hemodialysis patients.
Chen CF; Lin CC
J Vasc Access; 2019 May; 20(1_suppl):24-30. PubMed ID: 29512407
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the survival of permanent vascular access ports].
Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
[TBL] [Abstract][Full Text] [Related]
12. Hemodialysis Arteriovenous Vascular Access Creation After Kidney Transplant Failure.
Zhang JC; Al-Jaishi A; Perl J; Garg AX; Moist LM
Am J Kidney Dis; 2015 Oct; 66(4):646-54. PubMed ID: 25975965
[TBL] [Abstract][Full Text] [Related]
13. Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.
Stefoni S; Cianciolo G; Donati G; Dormi A; Silvestri MG; Colì L; De Pascalis A; Iannelli S
Kidney Int; 2002 Jan; 61(1):324-35. PubMed ID: 11786115
[TBL] [Abstract][Full Text] [Related]
14. Brachiobasilic arteriovenous fistula: different surgical techniques and their effects on fistula patency and dialysis-related complications.
Hossny A
J Vasc Surg; 2003 Apr; 37(4):821-6. PubMed ID: 12663983
[TBL] [Abstract][Full Text] [Related]
15. Association of TGF-beta1 polymorphisms with chronic renal disease.
Coll E; Cormand B; Campos B; González-Núñez D; Iñigo P; Botey A; Poch E
J Nephrol; 2004; 17(6):794-9. PubMed ID: 15593053
[TBL] [Abstract][Full Text] [Related]
16. Relation between gender and vascular access complications in hemodialysis patients.
Astor BC; Coresh J; Powe NR; Eustace JA; Klag MJ
Am J Kidney Dis; 2000 Dec; 36(6):1126-34. PubMed ID: 11096036
[TBL] [Abstract][Full Text] [Related]
17. The effect of the keyhole technique on diabetic patients undergoing autologous brachiobasilic transposition of an arteriovenous fistula.
Kayacioglu I; Baysal A; Ates M; Vural U; Balci AY; Saskin H; Celik A; Alkan RP; Kanca A
Heart Surg Forum; 2007; 10(2):E147-52. PubMed ID: 17597041
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas.
Stracke S; Konner K; Köstlin I; Friedl R; Jehle PM; Hombach V; Keller F; Waltenberger J
Kidney Int; 2002 Mar; 61(3):1011-9. PubMed ID: 11849456
[TBL] [Abstract][Full Text] [Related]
19. Impact of reintervention for failing upper-extremity arteriovenous autogenous access for hemodialysis.
Hingorani A; Ascher E; Kallakuri S; Greenberg S; Khanimov Y
J Vasc Surg; 2001 Dec; 34(6):1004-9. PubMed ID: 11743552
[TBL] [Abstract][Full Text] [Related]
20. The impact of transvenous cardiac devices on vascular access patency in hemodialysis patients.
Tan CS; Jie C; Joe J; Irani ZD; Ganguli S; Kalva SP; Wicky S; Wu S
Semin Dial; 2013; 26(6):728-32. PubMed ID: 23458207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
